HE4 assay (Fujirebio Diagnostics Inc.) on the Architect platform (Abbott Diagnostics) for ovarian cancer monitoring
Record ID 32011000798
English
Authors' objectives:
In the United States, ovarian cancer causes approximately 3% of all cancers that occur in women, and it is the fifth most common cause of cancer death in women. The American Cancer Society estimates that, in 2010, there will be approximately 21,880 new cases of ovarian cancer in the United States, and approximately 13,850 women will die of the disease. The 5-year survival rate for ovarian cancer is 93% if treated before it has spread beyond the ovaries; however, more than 80% of these cancers are detected after this stage. After metastasis, the 5-year survival rate falls below 20%.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11589
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Ovarian Neoplasms
- Biomarkers, Tumor
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.